Ciprofibrate represses α2u-globulin expression in liver and inhibits d-limonene nephrotoxicity

Carcinogenesis

Volumn 17, Issue 2, 1996, Pages 311-316

  Alvares, Keith ^a   Subbarao, V ^a   Rao, M Sambasiva ^a   Reddy, Janardan K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 GLOBULIN; ANTIBODY; CIPROFIBRATE; LIMONENE; MESSENGER RNA; PEROXISOME PROLIFERATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; HEPATOMEGALY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MALE; NEPHROTOXICITY; NONHUMAN; NORTHERN BLOTTING; ORAL DRUG ADMINISTRATION; OXIDATION; PEROXISOME; PRIORITY JOURNAL; RAT; TRANSCRIPTION INITIATION;

ALPHA-GLOBULINS; ANIMALS; ANTILIPEMIC AGENTS; CARCINOGENS; CLOFIBRIC ACID; CYCLOHEXENES; ENZYME REPRESSION; IN SITU HYBRIDIZATION; KIDNEY; LIVER; MALE; MICROBODIES; RATS; RNA, MESSENGER; TERPENES;

EID: 0029927457     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.2.311     Document Type: Article

References (34)

1. Reddy,J.K. and Krishnakantha,T. (1975) Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science, 190, 787-789.
2. Moody,D.E. and Reddy,J.K. (1976) Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH U2-348. J. Cell. Biol., 71. 768-780.
3. Reddy,J.K. and Lalwani,N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-53.
4. Reddy,J.K., Azamoff,D.L. and Hignite,C.E. (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature (Lond.), 283, 397-398.
5. Rao,M.S. and Reddy,J.K. (1987) Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis, 8, 631-636.
6. Reddy,J.K., Goel,S.K., Nemali,M.R. et al. (1986) Transcriptional regulation of peroxisome fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-dehydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl Acad. Sci. USA, 83, 1747-1751.
7. Moody,D.E., Gibson,G.G., Grant,D.F., Magdalou,J. and Rao,M.S. (1990) Peroxisome proliferators, a unique set of drug metabolizing inducers: commentary on a symposium. Drug. Metab., 20, 779-791.
8. Issemann,I. and Green,S. (1990) Activation of a member of the steroid receptor hormone superfamily by peroxisome proliferators. Nature (Lond.), 347, 645-650.
9. Dreyer,C., Krey,G., Keller,H., Givel,F., Helftenbein,G. and Wahli,W. (1992) Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell, 68, 879-887.
10. Gearing,K.L., Gottlicher,M., Teboul,M., Widmark,E. and Gustafsson,J.A. (1993) Interaction of the peroxisome proliferator activated receptor and retinoid X receptor. Proc. Natl Acad. Sci. USA, 90, 1440-1444.
11. Roy,A.K. and Neuhaus,O.W. (1966) Proof of the hepatic synthesis of a sex-dependent protein in the rat. Biochim. Biophys. Acta, 127, 82-87.
12. 2u-globulin as demonstrated by immunohistochemistry and specific mRNA monitoring. Am. J. Anat., 165, 211-224.
13. 2u-globulin. J. Biol. Chem., 251, 3594-3598.
14. 2U-globulin and its messenger RNA. J. Biol. Chem., 258, 688-692.
15. 2u-globulin gene expression. Recent Prog. Harm. Res., 39, 425-461.
16. 2u-globulin. Kidney Int., 16, 409-415.
17. 2u-globulin nephropathy. Annu. Rev. Pharmacol. Toxicol., 30, 349-367.
18. 2u-globulin. Toxicol. Appl. Pharmacol., 91, 182-192.
19. 2u-globulin in 1,4-dichlorobenzene-induced nephropathy. Toxicol. Appl. Pharmacol., 99, 122-132.
20. 2u-globulin. Toxicol. Appl. Pharmacol., 99, 250-259.
21. 2u-globulin-xenobiotic conjugates. Toxicol. Appl. Pharmacol., 103, 539-548.
22. 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. Environ. Health Perspect., 99, 313-349.
23. 2u-globulin is necessary for d-limonene promotion of male rat kidney tumors. Cancer Res., 51, 3512-3521.
24. Chirgwin,J.M., Przybyla,A.E., MacDonald,R.J. and Rutter,W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299.
25. Nemali,M.R., Reddy,M.K., Usuda,N., Reddy,P.G., Comeau,L.D., Rao,M.S. and Reddy,J.K.(1989) Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Toxicol. Appl. Pharmacol., 97, 72-87.
26. Towbin,H., Staehlin,T. and Gordon,J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
27. 2u-globulin in rat liver. J. Endocrinol., 111, 205-208
28. Blobel,G. and Potter,V.R. (1966) Nuclei from rat liver: isolation method that combines purity with high yield. Science, 154, 1662-1665.
29. Mueckler,M.M., Moran,D. and Pitot,H.C. (1984) Transcriptional control of ornithine aminotransferase synthesis in rat kidney by estrogen and thyroid hormone. J. Biol. Chem., 259, 2032-2035.
30. Yeldandi,A.V., Tan,X., Dwivedi,R.S., Subbarao,V., Smith,D.D. Scarpelli,D.G., Rao,M.S. and Reddy,J.K. (1990) Coexpression of glutamine synthetase and carbamoylphosphate synthase I genes in pancreatic hepatocytes of rat. Proc. Natl Acad. Sci. USA, 87, 881-885.
31. Mancini,M.A., Song,C.S., Rao,T.A., Chaterjee,B. and Roy,A.K. (1992) Spatio-temporal expression of estrogen sulfotransferase within the hepatic lobule of male rats: implication of in situ estrogen inactivation in androgen action. Endocrinology, 131, 1541-1546.
32. 2u-globulin mRNA level in the rat liver. J. Cancer Res Clin Oncol., 119, 572-575.
33. 2u-globulin gene structure, transcription and mRNA translation in hepatomas. J. Biol. Chem., 257, 2727-2729.
34. Motojima,K., Goto,S. and Imanaka,T. (1992) Specific repression of transthyretin gene expression in rat liver by a peroxisome proliferator clofibrate. Biochem. Biophys. Res. Commun., 188, 799-806.